Systematic Investigation of a Potential Epidemiological and Genetic Association Between Male Androgenetic Alopecia and COVID-19

October 2021 in “ Skin health and disease ”

S. K. Henne, Lara M. Hochfeld, Carlo Maj, Markus M. Nöthen, Stefanie Heilmann-Heimbach

androgenetic alopecia COVID-19 WNT signaling vitamin metabolism polygenic risk score AGA

TLDR No significant link between male pattern baldness and COVID-19 severity was found.

This study examined the potential link between male androgenetic alopecia (AGA) and COVID-19 severity using data from 6,262 individuals in the UK Biobank. Among them, 3,101 men reported AGA status. The findings revealed no significant epidemiological association between AGA and COVID-19 severity after adjusting for age, and genetic analyses showed no general genetic correlation between the two conditions. However, pathway-based polygenic risk score analyses indicated a shared genetic component in specific pathways, such as WNT signaling and vitamin metabolism, which may connect the pathophysiologies of AGA and COVID-19. The study emphasizes the need for further research, especially in diverse populations, to explore these potential links.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Systematic Investigation of a Potential Epidemiological and Genetic Association Between Male Androgenetic Alopecia and COVID-19

2 citations , October 2021 in “Skin health and disease”

No significant link between male pattern baldness and COVID-19 severity was found.

Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients

research Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients

4 citations , May 2021 in “Journal of The European Academy of Dermatology and Venereology”

Hair loss doesn't affect COVID-19 severity.

Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial

research Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial

41 citations , February 2021 in “Cureus”

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

research Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men

139 citations , December 2020 in “Cell Stem Cell”

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign

research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign

32 citations , July 2020 in “Journal of The American Academy of Dermatology”

AGA linked to worse COVID-19 outcomes in men.

research Study of Serum Vitamin D Levels in Men with Premature Androgenetic Alopecia

8 citations , June 2020 in “International Journal of Dermatology”

Men with early hair loss have lower vitamin D levels.

research Dissection of Genetic Variation and Evidence for Pleiotropy in Male Pattern Baldness

58 citations , December 2018 in “Nature Communications”

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

research Androgen Modulation of Wnt/β-Catenin Signaling in Androgenetic Alopecia

39 citations , March 2018 in “Archives of Dermatological Research”

Androgens may block hair growth signals, targeting this could treat hair loss.

research Androgenetic Alopecia: Identification Of Four Genetic Risk Loci And Evidence For The Contribution Of WNT Signaling To Its Etiology

74 citations , June 2013 in “Journal of Investigative Dermatology”

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors

155 citations , December 2003 in “British Journal of Dermatology”

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Related Community Posts Join

6 / 1000+ results

community The Real Cause Of Androgenetic Alopecia

in Research/Science 675 upvotes 1 year ago

Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

in Research 865 upvotes 1 year ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

community Study: There is 70x Higher Unconjugated DHT in Feces Compared To Blood Levels in Young Adults - Gut Microbiota Manages DHT Recycling and Metabolism

in Research/Science 195 upvotes 4 months ago

Gut microbiota significantly influences androgen metabolism, impacting hair loss treatments like finasteride. Probiotics, dietary changes, and fecal microbiota transplants may help manage DHT levels and improve hair health.

community I bought a microscope, how does my scalp/hairs look? I've been suffering diffuse thinning and hair loss after covid and never recovered (2 yrs ago) I eat healthy, in shape and workout.

in Progress Pictures 87 upvotes 1 year ago

A person with hair loss since COVID-19 is considering treatments like finasteride and minoxidil but is hesitant due to potential side effects. Suggestions include visiting a dermatologist, using a ketoconazole shampoo, and considering that post-COVID hair loss might be an autoimmune response.

community BREEZULA COVID UPDATE: Filing for Special Protocol Assessment with FDA

in Research/Science 63 upvotes 5 years ago

The conversation discusses the progress of Clascoterone (Breezula) for hair loss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.

community I interviewed Kintor: GT20029 Clinical Trial Pictures. As well as KX826.

in Research/Science 156 upvotes 10 months ago

GT20029 and KX826 are promising hair loss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.

Similar Research

5 / 1000+ results

research Covid-19 and Male Androgenetic Alopecia: Systematic Investigation of a Potential Epidemiological and Genetic Association

October 2021 in “Journal of Investigative Dermatology”

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

research ESDR072 – COVID-19 and Male Androgenetic Alopecia: Systematic Investigation of a Potential Epidemiological and Genetic Association

September 2021

Association Between Genetically Predicted Leukocyte Telomere Length and Non-Scarring Alopecia: A Two-Sample Mendelian Randomization Study

research Association Between Genetically Predicted Leukocyte Telomere Length and Non-Scarring Alopecia: A Two-Sample Mendelian Randomization Study

4 citations , January 2023 in “Frontiers in Immunology”

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

research Androgenetic Alopecia in Men: An Update on Genetics

May 2024 in “Indian Journal of Dermatology”

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

research Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery

September 2025 in “Pharmaceutics”

Combining plant extracts with nanotechnology may improve hair loss treatments.